ArticleBreast cancer (Tokyo, Japan)2024

Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models.

Hongyan Zheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.